This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: DELL, HGSI, BLK

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

AEGON/Transamerica (AEG) upgraded to buy at TheStreet Ratings.

Apollo Global (APO) upgraded at Goldman to Buy, Goldman Sachs said. Company can deliver solid fee-related earnings growth. $17.50 price target.

Blackrock (BLK - Get Report) downgraded at Goldman to Neutral, Goldman Sachs said. Valuation call, based on a $203 price target.

BioMarin Pharmaceutical (BMRN) added to TPL at Citigroup. $45 price target. Recent pull back is a good entry point.

Blackstone (BX) upgraded at Goldman to Buy, Goldman Sachs said. $19 price target. Company has solid fundraising potential in real estate and credit markets.

Comerica (CMA) downgraded at Stifel from Hold to Sell, Stifel Nicolaus said. Valuation call.

Dell (DELL - Get Report) downgraded at Citigroup to Neutral from Buy, Citigroup said. $19 price target. Easy margin expansion is done.

Dell downgraded at Needham from Buy to Hold, Needham said. $17 price target. Stock will likely remain rangebound, given near-term growth headwinds.

Frontier (FTR) downgraded at Hudson Square from Buy to Hold, Hudson Square Research said. Dividend cut takes some luster off the stock.

Holly Energy (HEP) downgraded at UBS to Neutral from Buy, UBS said. $64 price target. Valuation call.

Human Genome (HGSI) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. Valuation call, based on an $11 price target.

Hibbett Sports (HIBB) downgraded at Needham from Buy to Hold, Needham said. Valuation call.

Kronos (KRO) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Company could be hurt by higher feedstock ore costs. $23 price target.

Medtronic (MDT) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $43 price target. Majority of the company's sales are in low-growth areas.

Medtronic downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $41 price target. Company faces continued growth headwinds.

Newfield Exploration (NFX) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $45 price target. Company cut its production guidance.

Tesla Motors (TSLA) rated new Buy at ThinkEquity. $39 price target. Company should continue to execute and remain an industry leader.

Urban Outfitters (URBN) upgraded at BMO to Outperform, BMO Capital said. $36 price target. Visibility is improving for the second half of the year and 2013.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
DELL $0.00 0.00%
BLK $372.98 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs